Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 29 June 2007:
Vol. 316. no. 5833, pp. 1855 - 1857
DOI: 10.1126/science.1145015
Prev | Table of Contents | Next

Perspectives

AIDS/HIV:
A Reversal of Fortune in HIV-1 Integration

Alan Engelman

A customized enzyme that effectively excises integrated HIV-1 from infected cells in vitro might one day help to eradicate virus from AIDS patients.

The author is in the Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02115, USA. E-mail: alan_engelman{at}dfci.harvard.edu

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)